Endpoints News 2026年4月6日 Stipple Bio launches with $100M to find more precise targets on cancer proteins
Endpoints News 2026年4月4日 Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more
Endpoints News 2026年4月2日 Trump signs order to put 100% pharma tariffs on drugs, countries without trade deals
Endpoints News 2026年4月2日 Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
Endpoints News 2026年4月2日 Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News 2026年4月2日 Drug substance maker raises prices due to energy crisis; SpectronRX gets $85M
Endpoints News 2026年4月2日 Lipocine's postpartum depression drug fails; AstraZeneca claims liver cancer win
Endpoints News 2026年4月2日 Alto Neuroscience shelves schizophrenia cognitive impairment program after Phase 2 miss
Endpoints News 2026年4月2日 Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News 2026年4月2日 Immunovant's FcRn drug fails in a pair of Phase 3 trials in thyroid eye disease